Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial

Abstract Clostridioides difficile infection (CDI) is a significant cause of hospital-acquired diarrhea, leading to high morbidity, recurrence, and healthcare costs. Probiotics like Saccharomyces boulardii show potential as an adjunct therapy to standard CDI treatment, but further trials are needed t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Taned Chitapanarux, Umaporn Wiracha, Poramed Winichakoon, Parichat Salee, Patrinee Traisathit
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-06-01
coleção:	Scientific Reports
Assuntos:	Clinical cure Clostridioides difficile infection Recurrence rates Saccharomyces boulardii Vancomycin
Acesso em linha:	https://doi.org/10.1038/s41598-025-04986-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!